These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12697651)

  • 1. In vitro activity of penicillin G/sulbactam compared with penicillin and other antibiotics against common organisms causing ear, nose and throat (ENT) infections.
    Wenzler S; Schmidt-Eisenlohr E; Daschner F
    J Antimicrob Chemother; 2003 May; 51(5):1312-4. PubMed ID: 12697651
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and pharmacokinetic studies of sulbactam/penicillin combinations in the treatment of ear, nose and throat infections.
    Federspil P; Schedler M; Kurt P; Tiesler E
    Drugs; 1988; 35 Suppl 7():80-3. PubMed ID: 3220011
    [No Abstract]   [Full Text] [Related]  

  • 3. [ENT antibiotic therapy: therapeutic guidelines. Part I].
    Federspil P
    HNO; 1991 Oct; 39(10):371-7. PubMed ID: 1748569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concept of indirect pathogenicity by beta-lactamase production, especially in ear, nose and throat infection.
    Brook I
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():63-72. PubMed ID: 2691486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modern antibiotic therapy in acute ORL infections. Results of a survey, bacteriological viewpoints and suggestions for antibiotic therapy].
    Pfammatter D; Lüthy R
    Schweiz Med Wochenschr; 1982 Sep; 112(36):1230-8. PubMed ID: 7134949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaerobic infections of the oral cavity and the ears, nose and throat.
    Gaustad P
    Scand J Gastroenterol Suppl; 1983; 85():68-73. PubMed ID: 6353557
    [No Abstract]   [Full Text] [Related]  

  • 7. Eradicating chronic ear, nose, and throat infections: a systematically conducted literature review of advances in biofilm treatment.
    Smith A; Buchinsky FJ; Post JC
    Otolaryngol Head Neck Surg; 2011 Mar; 144(3):338-47. PubMed ID: 21493193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guidelines for fighting penicillin resistant agents in the ear-nose-throat area].
    Schaal KP
    HNO; 1970 Apr; 18(4):105-11. PubMed ID: 4987429
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical pharmacology of sultamicillin].
    Gumułka WS; Rewerski W
    Pol Tyg Lek; 1993 Oct; 48 Suppl 2():3-6. PubMed ID: 8008664
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent intractable bacterial infections in otolaryngology].
    Harada T; Sakakura Y
    Nihon Rinsho; 1994 Feb; 52(2):502-6. PubMed ID: 8126910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical use of azidocillin in pediatrics. Evaluation of the clinical effectiveness and tolerance in respiratory and otorhinolaryngologic infections].
    Barbato G; Cavalieri S; Salerno A
    Minerva Pediatr; 1982 May; 34(10):469-74. PubMed ID: 6897099
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic results of aminocyclohexyl-penicillin for the infectious diseases in otorhinolaryngology].
    Sanbe T; Murakami H; Takeuchi M; Nishizaki K; Jo K
    Jibiinkoka; 1970 Jan; 42(1):71-6. PubMed ID: 5461397
    [No Abstract]   [Full Text] [Related]  

  • 13. [Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
    Barcelona L; Marín M; Stamboulian D
    Medicina (B Aires); 2008; 68(1):65-74. PubMed ID: 18416324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections of the ears, nose, and throat in children with primary immunodeficiencies.
    Haddad J; Brager R; Bluestone CD
    Arch Otolaryngol Head Neck Surg; 1992 Feb; 118(2):138-41. PubMed ID: 1540342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-antibiotic and post-beta-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum beta-lactamase-producing Gram-negative bacteria.
    Lavigne JP; Bonnet R; Michaux-Charachon S; Jourdan J; Caillon J; Sotto A
    J Antimicrob Chemother; 2004 Apr; 53(4):616-9. PubMed ID: 14985275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of the electronic nose in the diagnosis of ear, nose and throat infection: a preliminary study.
    Shykhon ME; Morgan DW; Dutta R; Hines EL; Gardner JW
    J Laryngol Otol; 2004 Sep; 118(9):706-9. PubMed ID: 15509368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of bacterial pathogens against lincomycin/spectinomycin (1/2), penicillin G/neomycin (1/1), and penicillin G/dihydrostreptomycin (1/1) as determined in the BfT-GermVet monitoring program 2004-2006.
    Schwarz S; Werckenthin C; Alesík E; Wieler LH; Wallmann J
    Berl Munch Tierarztl Wochenschr; 2007; 120(9-10):363-71. PubMed ID: 17939451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroencephalographic effects of flucloxacillin in rats.
    Contreras S; Kramer MV; Pesce ME
    Pharmacol Toxicol; 1993; 72(4-5):205-7. PubMed ID: 8372038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactamase-producing bacteria in mixed infections.
    Brook I
    Clin Microbiol Infect; 2004 Sep; 10(9):777-84. PubMed ID: 15355407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricting the use of ampicillin-sulbactam.
    Zavascki AP; Sandri AM
    J Hosp Infect; 2004 Feb; 56(2):165-6. PubMed ID: 15019231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.